118 completed, 27 recruiting, 23 unknown, 19 terminated. 217 Phase 2, 42 Phase 1, 27 Phase 3.
Follow Therapeutics: new trials by email Literature Review of Therapeutics trials Research Report on Therapeutics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL Treatment with blinatumomab given subcutaneously. - Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | University of Alberta | 80 | 2027-01-02 | 2026-08-12 |
| Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis Therapeutic Plasma Exchange, Rituximab, Intravenous immunoglobulin - Idiopathic Pulmonary Fibrosis | Phase 2 | Not yet recruiting | University of Alabama at Birmingham | 52 | 2026-12-01 | 2026-10-20 |
| Defibrio AED Study treatment with Defibrio AED - VF, VT | Phase 1 / Phase 2 | Not yet recruiting | Defibrio, LLC | 25 | 2026-11-01 | 2026-10-19 |
| OPTIMISE Lung SABR Five fraction Image-guided Stereotactic Ablative Radiotherapy (IG-SABR) treatment, Investigational three fraction image-guided Stereotactic Ablative Radiotherapy (IG-SABR) - Non Small Cell Lung Cancer | Phase 2 | Recruiting | Cancer Trials Ireland | 208 | 2026-10-01 | 2026-10-16 |
| Acceleration of Tooth Movement Using PRP and Photobiomodulation With Clear Aligners Platelet Rich Plasma (PRP) injection, photobiomodulation (PBM) Therapy, clear aligner(12-hour wear protocol) - Orthodontic Tooth Movement | Phase 1 / Phase 2 | Not yet recruiting | Sana'a University | 42 | 2026-09-01 | 2026-08-31 |
| Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors Discontinuing Bruton tyrosine kinase inhibitors (BTKi) therapy - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 45 | 2026-09-01 | 2026-08-05 |
| Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye Autologous Serum Tears (50% Autologous Serum Tears + 0.2% Sodium Hyaluronate), Biological - Autologous Serum Tears (50% Autologous Serum Tears + Balanced Saline Solution (BSS), Standard of Care (SOC) Treatment - Dry Eye, Eye Diseases | Phase 2 | Recruiting | University of Miami | 20 | 2026-07-21 | 2026-07-24 |
| Ketones for Opioid Craving Treatment with Ketone Supplement, Treatment with Placebo - Opioid Use Disorder | Phase 2 | Recruiting | University of Maryland, Baltimore | 50 | 2026-07-16 | 2026-08-25 |
| Staph Nasal Decolonization to Improve Function and Feeding Mupirocin Ointment [Treatment], Placebo - Radiation Mucositis, Staphylococcal Aureus Infection | Phase 2 | Not yet recruiting | David Palma | 126 | 2026-06-01 | 2026-05-01 |
| Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies Psychotherapy, Psilocybin, Survey Administration - Anxiety, Depression | Phase 2 | Active not recruiting | University of Washington | 16 | 2026-05-19 | 2026-10-29 |
| ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer Treatment - Recurrent or Metastatic Cervical Cancer | Phase 1 / Phase 2 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 41 | 2026-04-10 | 2026-04-21 |
| Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency RP-L301 - Pyruvate Kinase Deficiency | Phase 2 | Suspended | Rocket Pharmaceuticals Inc. | 10 | 2026-04-01 | 2026-04-16 |
| JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis treated with JAK inhibitors orally for 28 days - Immune Checkpoint Inhibitor-Induced Dermatitis | Phase 2 | Not yet recruiting | Shixiu Wu | 35 | 2026-03-25 | 2026-04-15 |
| A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression Treatment with Ketamine Hydrochloride Prolonged-Release Tablets - Major Depressive Disorder (MDD) | Phase 2 | Active not recruiting | Daniel Lindqvist | 12 | 2026-03-13 | 2026-06-18 |
| HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma（FASTIL-Mela02） Tumor Tissue Sampling, Lymphodepletion Conditioning, Infusion of HS-IT101 Injection - Melanoma (Excluding Uveal Melanoma) | Phase 2 | Recruiting | Hangzhou Huasai Biomedicine Co., Ltd. | 90 | 2026-02-26 | 2026-10-27 |
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection Vonoparazan, Vitamin D, Probiotic - HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection | Phase 2 | Recruiting | Tanta University | 132 | 2026-02-15 | 2026-09-09 |
| Ketamine for Opioid Use Disorder Treatment with Ketamine, Treatment with Very Low Dose Ketamine - Opioid Use Disorder | Phase 2 | Recruiting | University of Maryland, Baltimore | 50 | 2026-02-04 | 2026-10-20 |
| A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders Midomafetamine, Non-directive therapy, Therapy - Anorexia Nervosa Restricting Type, Binge-Eating Disorder | Phase 2 | Withdrawn | Resilient Pharmaceuticals | 2026-02-01 | 2024-10-31 | |
| Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer. Treatment - Ovariancancer, Platinum-sensitive Recurrent | Phase 2 | Not yet recruiting | Peking University Third Hospital | 30 | 2026-01-04 | 2026-01-21 |
| Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma Treatment with the Tafa+Len+ standard immunotherapy regimen (e.g., R-ICE, R-DHAP, R-GDP, etc.) - Relapsed/Refractory Diffuse Large B Cell Lymphoma | Phase 2 | Active not recruiting | The First Affiliated Hospital of Soochow University | 25 | 2026-01-01 | 2026-06-02 |
Showing 20 of 217. Sign in to see all of them.
Depression (15) · Stress Disorders, Post-Traumatic (14) · Depressive Disorder, Major (11) · Anxiety Disorders (9) · Substance-Related Disorders (9) · Alcoholism (7) · Breast Neoplasms (6) · Lymphoma, Follicular (6) · Lymphoma, Large B-Cell, Diffuse (6) · Multiple Myeloma (6) · Opioid-Related Disorders (6) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Lymphoma, Mantle-Cell (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Prostatic Neoplasms (5)
Resilient Pharmaceuticals (10) · University of Washington (5) · University of Pittsburgh (4) · Fred Hutchinson Cancer Center (3) · Memorial Sloan Kettering Cancer Center (3) · The University of Texas Health Science Center, Houston (3) · University of Alabama at Birmingham (3) · University of Pennsylvania (3) · Yonsei University (3) · Alliance for Clinical Trials in Oncology (2) · Assistance Publique - Hôpitaux de Paris (2) · Fei Li (2) · Fondazione Policlinico Universitario Campus Bio-Medico (2) · Indiana University (2) · Medical University of South Carolina (2)
United States (108) · China (18) · Canada (11) · France (11) · United Kingdom (9) · Brazil (5) · Italy (5) · Spain (5) · Switzerland (5) · Germany (4) · Netherlands (4) · Sweden (4) · Australia (3) · Hong Kong (3) · South Korea (3)
Julian Ford, Ph.D. (2) · Michael C Mithoefer, MD (2) · Michael Mithoefer, MD (2) · Peter Manza, PhD (2) · Pierre Chue, MBBCh (2) · Aaron T Beck, MD (1) · Adele Lafrance, PhD (1) · Adrian Raine (1) · Ailton Melo, PhD (1) · Alan Ho, MD, PhD (1) · Albert KK Chung, MBBS(HK) (1) · Aleksandra Zgierska, MD PhD (1) · Ali Ataya, MD (1)
PMID 31065731, PMID 31572236, PMID 32500209, PMID 26083430, PMID 32368793, PMID 34658014, PMID 38509495, PMID 40342086, PMID 12777656, PMID 12877429, PMID 15001284, PMID 15119583, PMID 15214887, PMID 15616839, PMID 16009415, PMID 16211552, PMID 17262225, PMID 17288322, PMID 17585107, PMID 17675522, PMID 17845167, PMID 18228057, PMID 18666493, PMID 18717178, PMID 18762591, PMID 19321268, PMID 19411519, PMID 19454920, PMID 19830963, PMID 20005565, PMID 20126467, PMID 20643699, PMID 20687837, PMID 20978636, PMID 21109011, PMID 21266777, PMID 21373184, PMID 21457679, PMID 21755378, PMID 21762980, PMID 21969420, PMID 21981909, PMID 22296967, PMID 22863663, PMID 22951358, PMID 22969732, PMID 23098171, PMID 23118021, PMID 23172889, PMID 23262513
2019 (5), 2023 (3), P30CA015704 (2), P50DA009262 (2), U10CA180821 (2), 2015 (1), 2018 (1), 2025 (1), 2KL2TR001870 (1), 5UG1DA040316-05 (1), K23AA017508 (1), K23DA021512 (1), K23MH082824 (1), P01CA018029 (1), P30AG022845 (1)